Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for difficult‑to‑treat bacterial ...
Antibiotics, our infantry against bacteria, are losing their ability to fight against bacterial infections due to the rise of ...
A study evaluates disinfectants for decontaminating dropped implants in surgery, highlighting risks and the efficacy of CHG ...
We thank Alberto Enrico Maraolo and colleagues for their careful reading of our Seminar1 on community-acquired pneumonia and for raising an important point: the expanding therapeutic armamentarium ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results